In 2023, Daniel Faga earned $992.94K in total compensation at AnaptysBio, Inc., including $640.61K salary and $352.33K bonus. Most recently sold 148,940 shares in Mar 2024. Currently holds stock worth $19.71M. Led AnaptysBio, Inc. as CEO for 1 years.
Compensation History
Annual executive compensation data for Daniel Faga, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$992.94K
Salary
$640.61K
Bonus
$352.33K
Other
$0.00
Salary
$640.61KBoard Justification
The compensation program is designed to reward executive officers at a level consistent with overall strategic and financial performance, with a significant portion tied to performance metrics and stockholder returns.
Bonus
$352.33KBoard Justification
The annual target cash bonus opportunity of up to 55% of base salary, earned based on the achievement of specified performance goals for 2023.
Other Compensation
$0.00Board Justification
No additional compensation was reported outside of salary and bonus for 2023.
Restricted Stock
Board Justification
No stock was vested in 2023 as the focus is on cash compensation and performance-based bonuses.
Performance Metrics
Performance metrics for the 2023 cash bonus plan included corporate goals related to clinical trials and financial management.
Daniel Faga
Ex-CEO of AnaptysBio, Inc.
Education
MBA from Harvard Business School
Field of Expertise
Healthcare & Life Sciences - Biotechnology
Sector of Economy
Healthcare
Born
November 20, 1977 - 48 years ago
CEO of AnaptysBio, Inc. for
1 year 2 months (Apr 2022 - Jun 2023)
Previous Experience
Chief Operating Officer at Mirati Therapeutics
Holdings
Track Daniel Faga's stock holdings and portfolio value over time.
Total Stock Sold
$3.38M
$3.38M
155,806 ANAB shares
What if they kept their stock?
If Daniel Faga didn't sell their stock, today they would have:
Extra ANAB155,806 shares worth $6.93M.
This is 105.13% and $3.55M more than what they got when they sold the stock.
Insider Trading
Daniel Faga's recent stock transactions, purchases, and sales filed with the SEC.
$3.29M
ANAB at $22.10/share
Mar 22, 2024
Sale
$149.75K
ANAB at $21.81/share
Jan 6, 2024
Sale
887,043 shares
ANAB
Mar 21, 2022
Received
Rivals
Compare Daniel Faga with competitor CEOs and industry peers.